{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:56:17Z","timestamp":1790427377816,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T00:00:00Z","timestamp":1505347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of the West Indies, Cave Hill"},{"name":"Caribbean Public Health Research Agency"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10552-017-0959-y","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T05:58:14Z","timestamp":1505368694000},"page":"1323-1332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Human papillomavirus genotype distribution in cervical samples among vaccine na\u00efve Barbados women"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-3991","authenticated-orcid":false,"given":"Juann M.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kolin","family":"Schmalenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick A.","family":"Antonishyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Levett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marquita V.","family":"Gittens-St.Hilaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"959_CR1","volume-title":"The Pink Book: Human papillomavirus: epidemiology and prevention of vaccine-preventable diseases","author":"Prevention CfDCa","year":"2012","unstructured":"Prevention CfDCa (2012) The Pink Book: Human papillomavirus: epidemiology and prevention of vaccine-preventable diseases. Centers for Disease Control and Prevention, Atlanta"},{"issue":"10","key":"959_CR2","doi-asserted-by":"publisher","first-page":"K1K16","DOI":"10.1016\/j.vaccine.2008.05.064","volume":"26","author":"FX Bosch","year":"2008","unstructured":"Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Mu\u00f1oz N (2008) Epidemiology and natural history of Human Papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(10):K1\u2013K16. doi: 10.1016\/j.vaccine.2008.05.064","journal-title":"Vaccine"},{"issue":"6","key":"959_CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<827::AID-IJC6>3.0.CO;2-P","volume":"80","author":"DM Parkin","year":"1999","unstructured":"Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80(6):827\u2013841","journal-title":"Int J Cancer"},{"issue":"Suppl 3","key":"959_CR4","first-page":"S3\/11","volume":"24","author":"DM Parkin","year":"2006","unstructured":"Parkin DM, Bray F (2006) Chap. 2: the burden of HPV-related cancers. Vaccine 24(Suppl 3):S3\/11\u2013S25","journal-title":"Vaccine"},{"issue":"5","key":"959_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/cncr.20064","volume":"100","author":"SS Wang","year":"2004","unstructured":"Wang SS, Sherman ME, Hildesheim A, Lacey JV, Devesa S (2004) Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976\u20132000. Cancer 100(5):1035\u20131044. doi: 10.1002\/cncr.20064","journal-title":"Cancer"},{"issue":"3","key":"959_CR6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1055-9965.EPI-04-0569","volume":"14","author":"F Bray","year":"2005","unstructured":"Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, Hakama M, Parkin DM (2005) Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomark Prev 14(3):677\u2013686","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"959_CR7","doi-asserted-by":"publisher","unstructured":"Luciani S, Andrus JK (2008) A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean. Reprod Health Matters 16(32):59\u201366. doi: 10.1016\/s0968-8080(08)32405-7","DOI":"10.1016\/s0968-8080(08)32405-7"},{"issue":"1","key":"959_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM de Villiers","year":"2004","unstructured":"de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17\u201327. doi: 10.1016\/j.virol.2004.03.033","journal-title":"Virology"},{"key":"959_CR9","volume-title":"Cancer facts and figures","author":"Society AC","year":"2014","unstructured":"Society AC (2014) Cancer facts and figures. The Society, Atlanta"},{"key":"959_CR10","unstructured":"Organization WH (2013) Human papillomavirus fact sheet"},{"issue":"11","key":"959_CR11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1086\/428779","volume":"191","author":"PE Castle","year":"2005","unstructured":"Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD (2005) A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 191(11):1808\u20131816. doi: 10.1086\/428779","journal-title":"J Infect Dis"},{"issue":"1","key":"959_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88(1):63\u201373. doi: 10.1038\/sj.bjc.6600688","journal-title":"Br J Cancer"},{"issue":"11","key":"959_CR13","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/ijc.22241","volume":"119","author":"S Franceschi","year":"2006","unstructured":"Franceschi S, Herrero R, Clifford GM, Snijders PJF, Arslan A, Anh PTH, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao Y-L, Rajkumar R, Ronco G, de Sanjos\u00e9 S, Shin H-R, Sukvirach S, Thomas JO, Meijer CJLM, Mu\u00f1oz N, the IHPVPSSG (2006) Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119 (11):2677\u20132684. doi: 10.1002\/ijc.22241","journal-title":"Int J Cancer"},{"issue":"9271","key":"959_CR14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","volume":"357","author":"CB Woodman","year":"2001","unstructured":"Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357(9271):1831\u20131836","journal-title":"Lancet"},{"issue":"4","key":"959_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/sti.79.4.348","volume":"79","author":"S Sanjose de","year":"2003","unstructured":"de Sanjose S, Bosch FX, Tafur LA, Nascimento CM, Izarzugaza I, Izquierdo A, Barricarte A, Shah KV, Meijer CJLM, Mu\u00f1oz N (2003) Clearance of HPV infection in middle aged men and women after 9 years\u2019 follow up. Sex Transm Infect 79(4):348. doi: 10.1136\/sti.79.4.348","journal-title":"Sex Transm Infect"},{"issue":"6","key":"959_CR16","first-page":"485","volume":"12","author":"H Richardson","year":"2003","unstructured":"Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutl\u00e9e F, Franco EL (2003) The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomark Prev 12(6):485\u2013490","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"18","key":"959_CR17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","volume":"87","author":"GY Ho","year":"1995","unstructured":"Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87(18):1365\u20131371","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"959_CR18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1086\/315805","volume":"182","author":"KK Thomas","year":"2000","unstructured":"Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, Koutsky LA (2000) Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 182(4):1097\u20131102","journal-title":"J Infect Dis"},{"key":"959_CR19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/317638","volume":"183","author":"KL Liaw","year":"2001","unstructured":"Liaw KL (2001) A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183:8\u201315","journal-title":"J Infect Dis"},{"issue":"12","key":"959_CR20","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1086\/324579","volume":"184","author":"M-C Rousseau","year":"2001","unstructured":"Rousseau M-C, Pereira JS, Prado JCM, Villa LL, Rohan TE, Franco EL (2001) Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 184(12):1508\u20131517. doi: 10.1086\/324579","journal-title":"J Infect Dis"},{"issue":"6","key":"959_CR21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/342972","volume":"186","author":"GY Ho","year":"2002","unstructured":"Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, Burk RD (2002) Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 186(6):737\u2013742","journal-title":"J Infect Dis"},{"issue":"2","key":"959_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1086\/426867","volume":"191","author":"DR Brown","year":"2005","unstructured":"Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD (2005) A Longitudinal Study of Genital Human Papillomavirus Infection in a Cohort of Closely Followed Adolescent Women. J Infect Dis 191(2):182\u2013192. doi: 10.1086\/426867","journal-title":"J Infect Dis"},{"issue":"6","key":"959_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/infdis\/jiq131","volume":"203","author":"NG Campos","year":"2011","unstructured":"Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M (2011) Persistence of concurrent Infections with multiple human papillomavirus types: a population-based cohort study. J Infect Dis 203(6):823\u2013827. doi: 10.1093\/infdis\/jiq131","journal-title":"J Infect Dis"},{"key":"959_CR24","unstructured":"American Cancer Society (2016) Cancer Facts and Figures. American Cancer Society, Atlanta, GA. https:\/\/www.cancer.org\/cancer\/cervical-cancer\/references.html . Accessed 26 July 2017"},{"issue":"7","key":"959_CR25","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1086\/444391","volume":"192","author":"F M\u00e9ndez","year":"2005","unstructured":"M\u00e9ndez F, Mu\u00f1oz N, Posso H, Molano M, Moreno V, van den Brule AJC, Ronderos M, Meijer C, Group INdCHPS (2005) Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 192(7):1158\u20131165. doi: 10.1086\/444391","journal-title":"J Infect Dis"},{"key":"959_CR26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"issue":"1","key":"959_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","volume":"19","author":"N Mu\u00f1oz","year":"2000","unstructured":"Mu\u00f1oz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19(1):1\u20135","journal-title":"J Clin Virol"},{"issue":"6","key":"959_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, Snijders PJF, Meijer CJLM (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518\u2013527. doi: 10.1056\/NEJMoa021641","journal-title":"N Engl J Med"},{"issue":"9","key":"959_CR29","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1158\/1055-9965.epi-10-0131","volume":"19","author":"FM Carozzi","year":"2010","unstructured":"Carozzi FM, Tornesello ML, Burroni E, Loquercio G, Carillo G, Angeloni C, Scalisi A, Macis R, Chini F, Buonaguro FM, Giorgi Rossi P (2010) Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomark Prev 19(9):2389\u20132400. doi: 10.1158\/1055-9965.epi-10-0131","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"959_CR30","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1002\/j.1460-2075.1992.tb05487.x","volume":"11","author":"T Crook","year":"1992","unstructured":"Crook T, Vousden KH (1992) Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens. EMBO J 11(11):3935\u20133940","journal-title":"EMBO J"},{"issue":"9","key":"959_CR31","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.73.9.7590-7598.1999","volume":"73","author":"SE Seavey","year":"1999","unstructured":"Seavey SE, Holubar M, Saucedo LJ, Perry ME (1999) The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF). J Virol 73(9):7590\u20137598","journal-title":"J Virol"},{"key":"959_CR32","unstructured":"US Food and Drug Administration (2006)"},{"key":"959_CR33","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"LA Koutsky","year":"2002","unstructured":"Koutsky LA (2002) A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645\u20131651","journal-title":"N Engl J Med"},{"key":"959_CR34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"LL Villa","year":"2005","unstructured":"Villa LL (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271\u2013278","journal-title":"Lancet Oncol"},{"issue":"10","key":"959_CR35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrc1973","volume":"6","author":"R Roden","year":"2006","unstructured":"Roden R, Wu TC (2006) How will HPV vaccines affect cervical cancer? Nat Rev Cancer 6(10):753\u2013763","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"959_CR36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","volume":"297","author":"EF Dunne","year":"2007","unstructured":"Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (2007) Prevalence of HPV infection among females in the United States. J Am Med Assoc 297(8):813\u2013819","journal-title":"J Am Med Assoc"},{"key":"959_CR37","first-page":"1","volume":"56","author":"LE Markowitz M","year":"2007","unstructured":"Markowitz M LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 56:1\u201324","journal-title":"Morb Mortal Wkly Rep"},{"issue":"Suppl 3","key":"959_CR38","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.vaccine.2006.06.014","volume":"24","author":"LA Koutsky","year":"2006","unstructured":"Koutsky LA, Harper DM (2006) Current findings from prophylactic HPV vaccine trials. Vaccine 24(Suppl 3):S114\u2013S121","journal-title":"Vaccine"},{"issue":"1","key":"959_CR39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/0255-0857.31055","volume":"25","author":"MPA Gnanamony","year":"2007","unstructured":"Gnanamony M PA, Abraham P (2007) An overview of human papillomaviruses and current vaccine strategies. Indian J Med Microbiol 25(1):10\u201317","journal-title":"Indian J Med Microbiol"},{"key":"959_CR40","first-page":"220","volume":"29","author":"GM Andall-Brereton","year":"2011","unstructured":"Andall-Brereton GM, Hosein F, Salas RA, Mohammed W, Monteil MA, Goleski V, Severini A, Quesnel SMM, Carrington CVF, Boodram LL, Boisson E, Akpaka PE, Paul RC (2011) Human papillomavirus genotypes and their prevalence in a cohort of women in Trinidad. Rev Panam Salud Publica 29:220\u2013226","journal-title":"Rev Panam Salud Publica"},{"key":"959_CR41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S1020-49892013000300001","volume":"33","author":"K Lewis-Bell","year":"2013","unstructured":"Lewis-Bell K, Luciani S, Unger ER, Hariri S, McFarlane S, Steinau M, Prieto-Lara E, Vicari AS, Irons B, Lewis MJ, Andrus JK (2013) Genital human papillomaviruses among women of reproductive age in Jamaica. Rev Panam Salud Publica 33:159\u2013165","journal-title":"Rev Panam Salud Publica"},{"key":"959_CR42","unstructured":"Organization WH (2016) Human Papillomavirus and Cervical Cancer. 2"},{"issue":"1","key":"959_CR43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","volume":"57","author":"KS Cuschieri","year":"2004","unstructured":"Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E (2004) Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 57(1):68\u201372","journal-title":"J Clin Pathol"},{"issue":"1","key":"959_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1\u201317. doi: 10.1128\/CMR.16.1.1-17.2003","journal-title":"Clin Microbiol Rev"},{"issue":"0 5","key":"959_CR45","doi-asserted-by":"publisher","first-page":"F32-F46","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H Vuyst De","year":"2013","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP (2013) The burden of human papillomavirus infections and related diseases in sub-Saharan Africa. Vaccine 31(0 5):F32-F46. doi: 10.1016\/j.vaccine.2012.07.092","journal-title":"Vaccine"},{"key":"959_CR46","unstructured":"CDC a (2012) Cervical cancer screening guidelines for average-risk women. 2"},{"issue":"6","key":"959_CR47","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1128\/JCM.43.6.2662-2667.2005","volume":"43","author":"MAPC Ham van","year":"2005","unstructured":"van Ham MAPC, Bakkers JMJE, Harbers GK, Quint WGV, Massuger LFAG, Melchers WJG (2005) Comparison of Two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol 43(6):2662\u20132667. doi: 10.1128\/JCM.43.6.2662-2667.2005","journal-title":"J Clin Microbiol"},{"issue":"5a","key":"959_CR48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","volume":"102","author":"L Koutsky","year":"1997","unstructured":"Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102(5a):3\u20138","journal-title":"Am J Med"},{"issue":"3","key":"959_CR49","doi-asserted-by":"publisher","first-page":"e0119755","DOI":"10.1371\/journal.pone.0119755","volume":"10","author":"T Agorastos","year":"2015","unstructured":"Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC, the Hsg (2015) Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology. PLoS ONE 10 (3):e0119755. doi: 10.1371\/journal.pone.0119755","journal-title":"PLoS ONE"},{"issue":"9","key":"959_CR50","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1080\/07357900801975280","volume":"26","author":"C Ragin","year":"2008","unstructured":"Ragin C, Edwards R, Heron DE, Kuo J, Wentzel E, Gollin SM, Taioli E (2008) Prevalence of cancer-associated viral infections in healthy afro-Caribbean populations: a review of the literature. Cancer Invest 26(9):936\u2013947. doi: 10.1080\/07357900801975280","journal-title":"Cancer Invest"},{"issue":"4","key":"959_CR51","first-page":"220","volume":"29","author":"GM Andall-Brereton","year":"2011","unstructured":"Andall-Brereton GM, Hosein F, Salas RA, Mohammed W, Monteil MA, Goleski V, Severini A, Quesnel SM, Carrington CV, Boodram LL, Boisson E, Akpaka PE, Paul RC (2011) Human papillomavirus genotypes and their prevalence in a cohort of women in Trinidad. Rev Panam Salud Publica 29(4):220\u2013226","journal-title":"Rev Panam Salud Publica"},{"issue":"Suppl 1","key":"959_CR52","doi-asserted-by":"publisher","first-page":"S9-S9","DOI":"10.1186\/1750-9378-4-S1-S9","volume":"4","author":"CC Ragin","year":"2009","unstructured":"Ragin CC, Watt A, Markovic N, Bunker CH, Edwards RP, Eckstein S, Fletcher H, Garwood D, Gollin SM, Jackson M, Patrick AL, Smikle M, Taioli E, Wheeler VW, Wilson JB, Younger N, McFarlane-Anderson N (2009) Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer 4(Suppl 1):S9-S9. doi: 10.1186\/1750-9378-4-S1-S9","journal-title":"Infect Agent Cancer"},{"issue":"11","key":"959_CR53","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1128\/JVI.67.11.6424-6431.1993","volume":"67","author":"CK Ong","year":"1993","unstructured":"Ong CK, Chan SY, Campo MS, Fujinaga K, Mavromara-Nazos P, Labropoulou V, Pfister H, Tay SK, ter Meulen J, Villa LL et al (1993) Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 67(11):6424\u20136431","journal-title":"J Virol"},{"issue":"1","key":"959_CR54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0929-6646(10)60017-4","volume":"109","author":"KDK Lin","year":"2010","unstructured":"Lin K DK, Hung C, Wu TC (2010) Perspectives for preventive and therapeutic HPV vaccines. J Formos Med Assoc 109(1):4\u201324","journal-title":"J Formos Med Assoc"},{"key":"959_CR55","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/1471-2458-13-916","volume":"13","author":"IJ Chang","year":"2013","unstructured":"Chang IJ, Huang R, He W, Zhang SK, Wang SM, Zhao FH, Smith JS, Qiao YL (2013) Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health 13:916. doi: 10.1186\/1471-2458-13-916","journal-title":"BMC Public Health"},{"issue":"50","key":"959_CR56","doi-asserted-by":"publisher","first-page":"8026","DOI":"10.1016\/j.vaccine.2010.08.090","volume":"28","author":"SA Francis","year":"2010","unstructured":"Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, Thorpe RJ Jr (2010) Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine 28(50):8026\u20138032. doi: 10.1016\/j.vaccine.2010.08.090","journal-title":"Vaccine"},{"issue":"3","key":"959_CR57","doi-asserted-by":"publisher","first-page":"e90912","DOI":"10.1371\/journal.pone.0090912","volume":"9","author":"S Perlman","year":"2014","unstructured":"Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG (2014) Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS ONE 9(3):e90912. doi: 10.1371\/journal.pone.0090912","journal-title":"PLoS ONE"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0959-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T16:42:26Z","timestamp":1602952946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0959-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0959-y","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,14]]}}}